To investigate the role of p53 in response to genotoxic damage and oncogenesis we have constructed a unique knock-in mouse in which the endogenous p53 gene has been replace with one encoding a p53ER TAMfusion protein. In such animals, and in cells derived from them, competence for wild type p53 function appears to be completely dependent upon supply of the synthetic activating ligand 4-hydroxytamoxifen. We will validate and optimize this model and use it to establish the role, dependence and timing of p53 status in the response to DNA damage and oncogene activation in cells in vitro. We will also determine the efficacy of sustained or episodic p53 functional restoration in vivo in the response to DNA damage and in the prevention and regression of lymphoid and skin tumors. MDM2 and MDMX proteins are critical regulators of p53 whose loss leads to early embryonic lethality unless p53 is also absent. We will use our switchable p53ER TAMKI mice to establish the mechanism and timing of the dependency of MDM2/MDMX on p53 status and to explore p53 independent functions of both proteins. Our model will provide unique insights into the mechanism, timing and duration of p53-mediated tumor suppression as well unique information on the relationship between p53 and its MDM2 and MDMX regulators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA100193-05
Application #
7188602
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Blair, Donald G
Project Start
2003-03-15
Project End
2008-02-29
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
5
Fiscal Year
2007
Total Cost
$317,323
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Gamper, Ivonne; Burkhart, Deborah L; Bywater, Megan J et al. (2017) Determination of the physiological and pathological roles of E2F3 in adult tissues. Sci Rep 7:9932
Baek, Kwan-Hyuck; Bhang, Dongha; Zaslavsky, Alexander et al. (2013) Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest 123:4375-89
Shchors, Ksenya; Persson, Anders I; Rostker, Fanya et al. (2013) Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy. Proc Natl Acad Sci U S A 110:E1480-9
Garcia, Daniel; Warr, Matthew R; Martins, Carla P et al. (2011) Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev 25:1746-57
Junttila, Melissa R; Karnezis, Anthony N; Garcia, Daniel et al. (2010) Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature 468:567-71
Martins, Carla P; Brown-Swigart, Lamorna; Evan, Gerard I (2006) Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 127:1323-34